China-based Unitree Robotics has opened subscriptions for its Shanghai STAR Market IPO, aiming to raise $904 million. With 2025 revenue of 1.7 billion yuan and consistent profitability, the company is positioning itself as a leader in humanoid and quadruped robotics. However, investors are cautious about the sustainability of commercial adoption and potential global export restrictions that could impact future growth.
Unitree Robotics, a Chinese manufacturer known for its humanoid and quadrupedal robots, has officially launched its initial public offering on the Shanghai Stock Exchange’s STAR Market. The company has priced its shares at 150.8 yuan each, aiming to raise approximately 6.1 billion yuan ($904 million). This listing values the robotics firm at roughly 61 billion yuan ($9.04 billion), making it a significant event for the global robotics sector.
Unlike many artificial intelligence and robotics startups that often burn cash to fund growth, Unitree has reported consistent profitability. For the 2025 financial year, the company generated nearly 1.7 billion yuan in revenue, with an adjusted net profit of approximately 600 million yuan. Humanoid robots have become the primary driver of this income, accounting for over 51% of the company's total revenue.
Unitree first gained international attention for its cost-effective four-legged robots, often called "robot dogs." Since then, it has transitioned to developing advanced human-like robots, such as the G1, H1, and R1 models. These machines are designed for tasks that require human-like movement, such as walking, running, and interacting with physical environments. The company faces stiff competition from global giants like Tesla, which is developing the Optimus robot, and Boston Dynamics, as well as emerging domestic rivals like AgiBot and Leju Robotics.
Despite the enthusiasm surrounding the company’s technological capabilities, there are notable risks for investors to track. While revenue is growing, the current customer base is heavily concentrated within academic institutions and government-backed research projects. Widespread commercial demand from industries or households—a key requirement for mass-market success—is still in the early stages. This means the company’s future growth depends heavily on its ability to move beyond research use cases and find consistent industrial or consumer applications.
Another layer of uncertainty involves geopolitical factors. As a manufacturer of advanced technology, Unitree is potentially vulnerable to shifting international trade policies. Any new export restrictions from major markets like the United States could limit the company’s ability to sell its robots globally, which is a concern for its long-term expansion plans. Additionally, the robotics industry requires constant and heavy spending on research and development to stay ahead of competitors, which can put pressure on profit margins over time.
For investors following the sector, it is important to note that this is a mainland China listing. It is not directly accessible to most Indian retail investors through standard domestic trading accounts. The key monitorable for the company moving forward will be how quickly it can scale production and secure large-scale commercial contracts outside of the government and research sectors.